• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性阿片类物质可改善慢性阻塞性肺疾病(COPD)患者在跑步机运动期间的呼吸困难症状。

Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD.

作者信息

Mahler D A, Murray J A, Waterman L A, Ward J, Kraemer W J, Zhang X, Baird J C

机构信息

Section of Pulmonary and Critical Care Medicine, Dartmouth Medical School, Hanover, NH, USA.

出版信息

Eur Respir J. 2009 Apr;33(4):771-7. doi: 10.1183/09031936.00145208. Epub 2009 Feb 12.

DOI:10.1183/09031936.00145208
PMID:19213787
Abstract

Exogenous opioid drugs, such as morphine, relieve breathlessness. The present study hypothesis was that endogenous opioids, released during the stress of exercise, modify dyspnoea in patients with chronic obstructive pulmonary disease. After familiarisation, patients performed an incremental treadmill exercise test followed by constant work on the treadmill for 10 min. At subsequent visits (2 to 3 days apart), patients received two puffs of albuterol, had a catheter placed in an arm vein for removal of blood to measure beta-endorphin immunoreactivity, received normal saline or 10 mg of naloxone intravenously in randomised order, and then performed high-intensity constant work rate exercise on the treadmill. The mean+/-sd age of the 17 patients (eight females and nine males) was 63+/-7 yrs, and post-bronchodilator forced expiratory volume in one second was 50+/-17% predicted. In both conditions, beta-endorphin levels increased three-fold from rest to end-exercise. The regression slope of breathlessness as a function of oxygen consumption (primary outcome), mean ratings of breathlessness throughout exercise and peak ratings of breathlessness were significantly higher with naloxone than normal saline. There were no differences in physiological responses throughout exercise between conditions. In conclusion, endogenous opioids modify dyspnoea during treadmill exercise in patients with chronic obstructive pulmonary disease by apparent alteration of central perception.

摘要

外源性阿片类药物,如吗啡,可缓解呼吸困难。本研究的假设是,在运动应激期间释放的内源性阿片类物质会改变慢性阻塞性肺疾病患者的呼吸困难症状。在熟悉流程后,患者进行递增式跑步机运动试验,随后在跑步机上持续工作10分钟。在随后的访视(间隔2至3天)中,患者吸入两喷沙丁胺醇,通过置于手臂静脉的导管取血以测量β-内啡肽免疫反应性,然后按随机顺序静脉注射生理盐水或10毫克纳洛酮,之后在跑步机上进行高强度恒定工作率运动。17例患者(8名女性和9名男性)的平均年龄为63±7岁,支气管扩张剂使用后一秒用力呼气量为预测值的50±17%。在两种情况下,β-内啡肽水平从静息状态到运动结束时均增加了三倍。与生理盐水相比,纳洛酮治疗时,作为耗氧量函数的呼吸困难回归斜率(主要结果)、运动期间呼吸困难的平均评分以及呼吸困难的峰值评分均显著更高。两种情况下运动期间的生理反应无差异。总之,内源性阿片类物质通过明显改变中枢感知来改变慢性阻塞性肺疾病患者跑步机运动期间的呼吸困难症状。

相似文献

1
Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD.内源性阿片类物质可改善慢性阻塞性肺疾病(COPD)患者在跑步机运动期间的呼吸困难症状。
Eur Respir J. 2009 Apr;33(4):771-7. doi: 10.1183/09031936.00145208. Epub 2009 Feb 12.
2
Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD.内源性阿片肽对 COPD 患者抵抗性负荷呼吸时呼吸困难的强度和不适的神经调节作用。
COPD. 2011 Jun;8(3):160-6. doi: 10.3109/15412555.2011.560132. Epub 2011 Apr 22.
3
Physiological responses to high intensity, constant-load arm exercise in COPD.慢性阻塞性肺疾病患者对高强度、恒定负荷手臂运动的生理反应
Respir Med. 2008 Mar;102(3):348-53. doi: 10.1016/j.rmed.2007.10.020. Epub 2007 Dec 11.
4
Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.GOLD 1期慢性阻塞性肺疾病有症状患者在周期性运动期间呼吸困难的机制
Am J Respir Crit Care Med. 2008 Mar 15;177(6):622-9. doi: 10.1164/rccm.200707-1064OC. Epub 2007 Nov 15.
5
Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.对全球慢性阻塞性肺疾病倡议(GOLD)I 期慢性阻塞性肺疾病(COPD)症状患者急性支气管扩张剂可逆性的评估。
Thorax. 2009 Mar;64(3):216-23. doi: 10.1136/thx.2008.103598. Epub 2008 Dec 3.
6
Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.慢性阻塞性肺疾病患者吸入呋塞米后呼吸困难缓解及运动耐力改善的机制
Thorax. 2008 Jul;63(7):606-13. doi: 10.1136/thx.2007.085993. Epub 2008 Feb 4.
7
Does exercise test modality influence dyspnoea perception in obese patients with COPD?运动试验方式是否会影响肥胖 COPD 患者的呼吸困难感知?
Eur Respir J. 2014 Jun;43(6):1621-30. doi: 10.1183/09031936.00151513. Epub 2013 Dec 5.
8
Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.支气管扩张剂治疗后呼吸系统传导率改善可预测运动性呼吸困难减少。
Respir Med. 2011 Sep;105(9):1345-51. doi: 10.1016/j.rmed.2011.03.013. Epub 2011 Apr 8.
9
Antagonism of substance P and perception of breathlessness in patients with chronic obstructive pulmonary disease.物质 P 拮抗剂对慢性阻塞性肺疾病患者呼吸困难感知的影响。
Respir Physiol Neurobiol. 2014 Jun 1;196:1-7. doi: 10.1016/j.resp.2014.02.008. Epub 2014 Feb 25.
10
Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.枸橼酸芬太尼雾化吸入改善慢性阻塞性肺疾病患者高负荷等长运动耐力。
J Pain Symptom Manage. 2012 Apr;43(4):706-19. doi: 10.1016/j.jpainsymman.2011.05.007. Epub 2011 Dec 14.

引用本文的文献

1
The effect of acupuncture on exercise capacity in patients with COPD is mediated by improvements of dyspnea and leg fatigue: a causal mediation analysis using data from a randomized controlled trial.针刺对 COPD 患者运动能力的影响是通过改善呼吸困难和腿部疲劳来介导的:一项基于随机对照试验数据的因果中介分析。
BMC Complement Med Ther. 2024 Jan 20;24(1):44. doi: 10.1186/s12906-024-04353-0.
2
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review.固定强度运动试验测量慢性心肺人群的运动性呼吸困难:系统评价。
Eur Respir Rev. 2023 Aug 9;32(169). doi: 10.1183/16000617.0016-2023. Print 2023 Sep 30.
3
Biased, Bitopic, Opioid-Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction.
具有偏向性、双靶点、阿片-肾上腺素能连接的化合物可能会提高特异性、降低剂量,并增强激动剂或拮抗剂功能,同时降低耐受性和成瘾风险。
Pharmaceuticals (Basel). 2022 Feb 10;15(2):214. doi: 10.3390/ph15020214.
4
COPD significantly increases cerebral and cardiovascular events in hypertensives.慢性阻塞性肺疾病(COPD)显著增加高血压患者发生脑血管和心血管事件的风险。
Sci Rep. 2021 Apr 12;11(1):7884. doi: 10.1038/s41598-021-86963-z.
5
Management of Refractory Breathlessness: a Review for General Internists.难治性呼吸困难的管理:普通内科医生的综述。
J Gen Intern Med. 2021 Apr;36(4):1035-1040. doi: 10.1007/s11606-020-06439-0. Epub 2021 Jan 19.
6
Isolating peripheral effects of endogenous opioids in modulating exertional breathlessness in people with moderate or severe COPD: a randomised controlled trial.分离内源性阿片类物质对中度或重度慢性阻塞性肺疾病患者运动性呼吸困难的外周调节作用:一项随机对照试验。
ERJ Open Res. 2019 Dec 23;5(4). doi: 10.1183/23120541.00153-2019. eCollection 2019 Oct.
7
Controlled Delivery of 80 mg Aerosol Furosemide Does Not Achieve Consistent Dyspnea Relief in Patients.80 毫克雾化呋塞米控释输送未能为患者实现一致的呼吸困难缓解。
Lung. 2020 Feb;198(1):113-120. doi: 10.1007/s00408-019-00292-7. Epub 2019 Nov 15.
8
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial.口服美沙酮控释片治疗慢性心力衰竭呼吸困难:一项随机安慰剂对照试验。
ESC Heart Fail. 2019 Dec;6(6):1149-1160. doi: 10.1002/ehf2.12498. Epub 2019 Aug 6.
9
The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.HECT 泛素 E3 连接酶 Smurf2 通过泛素蛋白酶体系统在肺上皮细胞中降解 μ 阿片受体 1。
Am J Physiol Cell Physiol. 2019 May 1;316(5):C632-C640. doi: 10.1152/ajpcell.00443.2018. Epub 2019 Feb 13.
10
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.一项关于常规低剂量缓释吗啡治疗慢性呼吸困难的实用性、III期、多中心、双盲、安慰剂对照、平行组、剂量递增随机试验:呼吸困难、运动与硫酸吗啡(BEAMS)研究方案。
BMJ Open. 2017 Jul 17;7(7):e018100. doi: 10.1136/bmjopen-2017-018100.